Profile data is unavailable for this security.
About the company
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
- Revenue in USD (TTM)0.00
- Net income in USD-26.03m
- Incorporated2023
- Employees42.00
- LocationVivani Medical Inc1350 S. Loop RoadALAMEDA 94502United StatesUSA
- Phone+1 (415) 506-8462
- Websitehttps://vivani.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accuray Inc | 436.97m | -35.62m | 65.51m | 990.00 | -- | 1.23 | -- | 0.1499 | -0.2982 | -0.2982 | 3.89 | 0.4497 | 0.9434 | 2.10 | 5.82 | 441,382.80 | -7.69 | -1.60 | -13.56 | -2.72 | 27.83 | 35.04 | -8.15 | -1.75 | 0.7091 | -0.5193 | 0.7178 | -- | 2.68 | 3.67 | 89.77 | -- | 2.76 | -- |
| Neuraxis Inc | 3.36m | -8.37m | 67.11m | 21.00 | -- | 27.30 | -- | 19.96 | -1.02 | -1.02 | 0.4059 | 0.2311 | 0.9718 | 7.94 | 41.74 | 160,111.00 | -217.93 | -- | -1,360.57 | -- | 84.34 | -- | -224.24 | -- | 1.55 | -97.22 | 0.0789 | -- | 9.18 | -- | 42.21 | -- | -- | -- |
| DarioHealth Corp | 24.73m | -37.11m | 72.65m | 196.00 | -- | 0.971 | -- | 2.94 | -12.47 | -12.47 | 8.29 | 11.07 | 0.2173 | 2.22 | 6.51 | 126,183.70 | -37.17 | -63.89 | -42.41 | -75.30 | 56.86 | 34.31 | -171.09 | -262.34 | 4.02 | -69.69 | 0.2901 | -- | 32.86 | 29.04 | 35.47 | -- | 7.09 | -- |
| QT Imaging Holdings Inc | 18.92m | -21.08m | 72.87m | 20.00 | -- | 11.28 | -- | 3.85 | -2.21 | -2.21 | 1.81 | 0.5415 | 1.30 | 2.53 | 6.47 | -- | -144.85 | -- | -368.39 | -- | 45.36 | -- | -111.40 | -- | 2.17 | -1.75 | 0.4158 | -- | 287.91 | -- | -48.78 | -- | -- | -- |
| Sensus Healthcare Inc | 35.61m | -3.01m | 75.57m | 35.00 | -- | 1.47 | -- | 2.12 | -0.1847 | -0.1847 | 2.18 | 3.11 | 0.6028 | 1.32 | 2.71 | 1,017,400.00 | -5.09 | 13.01 | -5.66 | 14.98 | 47.95 | 61.32 | -8.44 | 19.45 | 5.27 | -- | 0.00 | -- | 71.31 | 8.93 | 1,270.52 | -- | -7.18 | -- |
| Positron Corp | 1.24m | -1.27m | 75.69m | 22.00 | -- | -- | -- | 61.19 | -0.0897 | -0.0897 | 0.0876 | -0.1109 | 0.5976 | 2.29 | 6.56 | -- | -61.35 | -224.13 | -- | -- | 32.98 | 9.85 | -102.67 | -201.87 | 0.0638 | -- | -- | -- | -10.06 | 0.2751 | 63.63 | -- | 4.36 | -- |
| InspireMD Inc | 7.78m | -46.20m | 77.54m | 85.00 | -- | 1.20 | -- | 9.97 | -0.8396 | -0.8396 | 0.139 | 1.53 | 0.1207 | 1.93 | 4.46 | 91,517.65 | -71.65 | -60.63 | -83.34 | -71.77 | 24.91 | 20.76 | -593.89 | -377.98 | 6.17 | -- | 0.00 | -- | 12.96 | 13.50 | -60.70 | -- | 37.62 | -- |
| Picard Medical Inc | 4.77m | -33.80m | 79.60m | 75.00 | -- | 9.99 | -- | 16.67 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Xtant Medical Holdings Inc | 133.08m | 1.75m | 80.00m | 217.00 | 55.91 | 1.59 | 11.97 | 0.6011 | 0.0102 | 0.0102 | 0.9158 | 0.3599 | 1.30 | 1.22 | 5.78 | 613,285.70 | 1.71 | -11.38 | 2.57 | -16.17 | 62.02 | 59.37 | 1.32 | -9.64 | 1.06 | 1.57 | 0.3635 | -- | 28.44 | 12.64 | -2,592.27 | -- | 36.16 | -- |
| MaxCyte Inc | 34.42m | -45.63m | 84.07m | 114.00 | -- | 0.4662 | -- | 2.44 | -0.4298 | -0.4298 | 0.3243 | 1.69 | 0.149 | 0.7657 | 5.35 | 301,921.10 | -19.75 | -13.01 | -21.30 | -14.01 | 79.97 | 87.32 | -132.58 | -72.43 | 7.27 | -- | 0.00 | -- | -6.44 | 12.31 | -8.26 | -- | 5.37 | -- |
| Neuronetics Inc | 129.87m | -44.50m | 88.35m | 716.00 | -- | 3.23 | -- | 0.6803 | -0.8344 | -0.8344 | 2.24 | 0.3997 | 1.18 | 13.87 | 7.31 | 181,386.90 | -40.63 | -29.61 | -52.56 | -36.96 | 50.43 | 74.98 | -34.35 | -53.71 | 2.09 | -4.31 | 0.6768 | -- | 4.96 | 3.63 | -44.78 | -- | 12.51 | -- |
| Vivani Medical Inc | 0.00 | -26.03m | 99.07m | 42.00 | -- | 57.33 | -- | -- | -0.4417 | -0.4417 | 0.00 | 0.0213 | 0.00 | -- | -- | 0.00 | -76.61 | -43.12 | -94.91 | -49.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 8.44 | -- | 2.43 | -- |
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 103.20m | 143.00 | -- | 2.10 | -- | 3.24 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Hyperfine Inc | 10.59m | -40.05m | 106.67m | 111.00 | -- | 3.17 | -- | 10.07 | -0.5243 | -0.5243 | 0.1385 | 0.3339 | 0.191 | 0.8859 | 1.81 | 95,414.41 | -72.23 | -45.05 | -88.25 | -48.86 | 46.12 | 30.47 | -378.17 | -757.55 | 3.06 | -- | 0.00 | -- | 16.84 | -- | 7.95 | -- | 9.44 | -- |
| Treace Medical Concepts Inc | 212.69m | -59.00m | 107.22m | 450.00 | -- | 1.22 | -- | 0.5041 | -0.9338 | -0.9338 | 3.36 | 1.36 | 1.04 | 1.14 | 5.13 | 472,644.40 | -28.95 | -25.72 | -34.49 | -30.95 | 79.81 | 80.88 | -27.74 | -26.93 | 3.13 | -21.30 | 0.3889 | -- | 1.59 | 29.96 | -5.85 | -- | 66.10 | -- |
| Alpha Teknova Inc | 39.80m | -18.22m | 127.40m | 173.00 | -- | 1.75 | -- | 3.20 | -0.3409 | -0.3409 | 0.7446 | 1.36 | 0.3435 | 3.77 | 8.17 | 230,063.60 | -15.73 | -19.57 | -16.94 | -20.97 | 30.97 | 38.24 | -45.78 | -63.70 | 4.27 | -28.65 | 0.1525 | -- | 2.89 | 12.68 | 27.28 | -- | -16.96 | -- |
Data as of Mar 03 2026. Currency figures normalised to Vivani Medical Inc's reporting currency: US Dollar USD
6.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.27m | 1.75% |
| Tudor Investment Corp.as of 31 Dec 2025 | 916.36k | 1.26% |
| Tanager Wealth Management LLPas of 31 Dec 2025 | 739.16k | 1.01% |
| Geode Capital Management LLCas of 31 Dec 2025 | 461.65k | 0.63% |
| Commonwealth Equity Services LLCas of 31 Dec 2025 | 330.53k | 0.45% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 263.83k | 0.36% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 229.94k | 0.32% |
| Monetary Management Group, Inc.as of 31 Dec 2025 | 193.98k | 0.27% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 144.87k | 0.20% |
| Marshall Wace LLPas of 31 Dec 2025 | 141.30k | 0.19% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
